Rocket One RKTO
NASDAQ RKTO
$0.70 +0.01 (+1.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rocket One (RKTO) Other Accumulated Expenses (2022)

Updated

Rocket One (RKTO) posted Other Accumulated Expenses of $50,000 for Q4 2022.

Analysis

Rocket One (RKTO) Other Accumulated Expenses (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rocket One 16.23 Mn -9.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 50,000.00
API Access

Rocket One Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RKTO&period=max&api_key=YOUR_API_KEY